COVID-19 and the cardiovascular system
- PMID: 32139904
- PMCID: PMC7095524
- DOI: 10.1038/s41569-020-0360-5
COVID-19 and the cardiovascular system
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects host cells through ACE2 receptors, leading to coronavirus disease (COVID-19)-related pneumonia, while also causing acute myocardial injury and chronic damage to the cardiovascular system. Therefore, particular attention should be given to cardiovascular protection during treatment for COVID-19.
Conflict of interest statement
The authors declare no competing interests.
Comment in
-
Interaction between RAAS inhibitors and ACE2 in the context of COVID-19.Nat Rev Cardiol. 2020 May;17(5):313. doi: 10.1038/s41569-020-0368-x. Nat Rev Cardiol. 2020. PMID: 32231328 Free PMC article. No abstract available.
-
Mechanisms by which angiotensin-receptor blockers increase ACE2 levels.Nat Rev Cardiol. 2020 Jun;17(6):378. doi: 10.1038/s41569-020-0387-7. Nat Rev Cardiol. 2020. PMID: 32332868 Free PMC article. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous